EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel Hybrids of Edaravone and 6‐Phenyl‐4,5‐dihydropyridazin‐3(2H)‐one with Antiplatelet Aggregation and Neuroprotection for Ischemic Stroke Treatment

Yi Li iD, Jieying He, Bilan Luo, Qinyang Yu, Ting Cai, Yong Li, Lingling Fan, Xunrong Zhou, Lei Tang

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202400110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Yi Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, College of Pharmacy, Guizhou Provincial Engineering Technology Research Cente…. Hauptthemen laut MEDLINE: Edaravone, Ischemic Stroke, Platelet Aggregation Inhibitors, Platelet Aggregation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Natural Science Foundation, Personnel Training Fund of Guizhou Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs with anti‐platelet aggregation and neuroprotection are of great significance for the treatment of ischemic stroke. A series of edaravone and 6‐phenyl‐4,5‐dihydropyridazin‐3(2H)‐one hybrids were designed and synthesized. Among them, 6g showed the most effective cytoprotective effect against oxygen‐glucose deprivation/reoxygenation‐induced damage in BV2 cells and an excellent inhibitory effect on platelet aggregation induced by adenosine diphosphate and arachidonic acid. Additionally, 6g could prevent thrombosis caused by ferric chloride in rats and pose a lower risk of causing bleeding compared with aspirin. It provides better protection against ischemia/reperfusion injury in rats compared with edaravone and alleviates the oxidative stress related to cerebral ischemia/reperfusion by increasing the GSH and SOD levels and decreasing the MDA concentration. Finally, molecular docking results showed that 6g probably acts on PDE3 A and plays an anti‐platelet aggregation effect. Overall, 6g could be a potential candidate compound for the treatment of ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EdaravoneIschemic StrokePlatelet Aggregation InhibitorsPlatelet AggregationNeuroprotective AgentsAnimalsRatsMolecular Docking SimulationMaleMiceMolecular StructureStructure-Activity RelationshipRats, Sprague-DawleyDrug DiscoveryPyridazinesOxidative Stress

Stichwörter der Autor:innen

6-phenyl-4,5-dihydropyridazin-3(2H)-oneEdaravoneanti-platelet aggregationcerebral ischemia/reperfusionneuroprotection

Substanzen

EdaravonePlatelet Aggregation InhibitorsNeuroprotective AgentsPyridazines

Autor:innen und Institutionen

  • State Key Laboratory of Functions and Applications of Medicinal Plants, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 561113,…
  • Department of Pharmacy, the, Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, 550003, P. R. China.

ORCID-Profile: Yi Li

Förderung

  • National Natural Science Foundation of China
  • Guizhou Provincial Natural Science Foundation
  • Personnel Training Fund of Guizhou Provincial Department of Education
  • Guizhou Province
  • Natural Science Foundation of Guizhou Province

Zitieren

APA

Li, Y., He, J., Luo, B., Yu, Q., Cai, T., Li, Y., Fan, L., Zhou, X., & Tang, L. (2024). Discovery of Novel Hybrids of Edaravone and 6‐Phenyl‐4,5‐dihydropyridazin‐3(2H)‐one with Antiplatelet Aggregation and Neuroprotection for Ischemic Stroke Treatment. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400110

Vancouver

Li Y, He J, Luo B, Yu Q, Cai T, Li Y, et al. Discovery of Novel Hybrids of Edaravone and 6‐Phenyl‐4,5‐dihydropyridazin‐3(2H)‐one with Antiplatelet Aggregation and Neuroprotection for Ischemic Stroke Treatment. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400110

BibTeX
@article{Li2024,
  author = {Li, Yi and He, Jieying and Luo, Bilan and Yu, Qinyang and Cai, Ting and Li, Yong and Fan, Lingling and Zhou, Xunrong and Tang, Lei},
  title = {Discovery of Novel Hybrids of Edaravone and 6‐Phenyl‐4,5‐dihydropyridazin‐3(2H)‐one with Antiplatelet Aggregation and Neuroprotection for Ischemic Stroke Treatment},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202400110}
}
Kostenlos starten →